Functional significance of the platelet alpha2-adrenoceptor: Studies in patients with myeloproliferative disorders
- 1 March 1984
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 33 (5) , 531-541
- https://doi.org/10.1016/0049-3848(84)90019-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Platelet Function Abnormalities in the Myeloproliferative DisordersScandinavian Journal of Haematology, 2009
- [3H]rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: Possible heterogeneity of α2-adrenoceptorsEuropean Journal of Pharmacology, 1982
- [3H]dihydroergocryptine binding to alpha-adrenergic receptors of human plateletsBiochemical Pharmacology, 1982
- Deficiency of Platelet Lipoxygenase Activity in Myeloproliferative DisordersNew England Journal of Medicine, 1982
- Platelets in Myeloproliferative DisordersScandinavian Journal of Haematology, 1981
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980
- INTERACTION OF SELECTIVE α‐ADRENOCEPTOR AGONISTS AND ANTAGONISTS WITH HUMAN AND RABBIT BLOOD PLATELETSBritish Journal of Pharmacology, 1980
- Platelet Function in Essential ThrombocythemiaNew England Journal of Medicine, 1978
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- Defective platelets in essential thrombocythemiaArchives of internal medicine (1960), 1969